Business
ASP Isotopes Inc. to Present at Canaccord Genuity Sustainability Summit on Wednesday, February 26, 2025
ASP Isotopes invites institutional investors to attend the upcoming virtual event by contacting their Canaccord Genuity representative Paul Mann, Chairman and
About this update from Asp Isotopes Inc.
[{"type":"text","content":"ASP Isotopes invites institutional investors to attend the upcoming virtual event by contacting their Canaccord Genuity representative Paul Mann, Chairman and Chief Executive Officer of ASP Isotopes, will participate in a panel discussion on the future of nuclear fission. The panel will also include representatives from TerraPower and Elementl Power WASHINGTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI (\"ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, is pleased to share that ASP Isotopes will participate in the Canaccord Genuity Sustainability Summit, a day of virtual presentations, panel discussions and 1x1 meetings with company executives and key opinion leaders, on Wednesday, February 26, 2025. From 9:30-10:10 a.m. Eastern Time, Paul Mann, Chairman and Chief Executive Officer, will participate in a panel discussion on the future of nuclear fission. Other participants in the panel discussion include Jeffrey Miller, Vice President, Business Development of TerraPower, LLC and Christopher Colbert, Chief Executive Officer of Elementl Power Inc. ASP Isotopes invites institutional investors to attend the virtual event by contacting their Canaccord Genuity representative. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (“ASP technology”). The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28 for enabling quantum computing; Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, Lithium-7 and Uranium-235 for green energy app...